WebCOMPANY: Dewpoint Therapeutics INDUSTRY: Engineering (Biomedical) Michael is currently Head of External Innovation at Dewpoint Therapeutics, where he leads search & evaluation of new technologies & assets, and as a member of the corporate development team focusing on partnerships, competitive intelligence and strategy. WebSep 29, 2024 · Dewpoint Therapeutics Raises $77M Series B Financing to Advance the Development of Drugs That Target Biomolecular Condensates Round led by ARCH Venture Partners Giuseppe Ciaramella, Ph.D.,...

Dewpoint Therapeutics - Contacts, Employees, Board …

WebBefore Dewpoint, Scott led Business Development efforts at Spero Therapeutics. Prior to that, he had successfully helped to build the development pipeline at Intarcia Therapeutics. He began his career as … WebFeb 16, 2024 · BOSTON, Feb. 16, 2024 /PRNewswire/ -- Dewpoint Therapeutics, the biomolecular condensates company, today announced that it has appointed Regina … the perico group

Dewpoint Therapeutics LinkedIn

WebBoard Member Regina Barzilay Regina Barzilay is a School of Engineering Distinguished Professor for AI and Health in the Department of Electrical Engineering and Computer Science and a member of the Computer Science and Artificial Intelligence Laboratory at the Massachusetts Institute of Technology. WebDewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Boston, Massachusetts, United States 101-250 Series C Private dewpointx.com 6,828 Actively Hiring - … WebThe mission of Leaps is to invest in breakthrough technologies and disruptive business models in the areas of healthcare and agriculture. Jürgen is currently a board member of BlueRock, Joyn Bio, Dewpoint, Khloris, Oerth Bio, Immunitas and eGenesis. the peridic table cerealelements